US Patent 8003783 17B-hydroxysteroid dehydrogenase inhibitors
Patent 8003783 was granted and assigned to Sterix Limited on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+60 characters)
Article
Patent abstract
There is provided a compound of Formula (III)
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Atul Purohit0
Barry Victor Lloyd Potter0
Christian Bubert0
Delphine Sophie Marion Fischer0
Gillian Margaret Allan0
Harshani Rithma Ruchiranani Lawrence0
Michael John Reed0
Nigel Vicker0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08003783 17B-hydroxysteroid dehydrogenase inhibitors US Patent 8003783 17B-hydroxysteroid dehydrogenase inhibitors
Infobox
Patent Number
080037830
Patent Number
80037830
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080037830
Date of Patent
August 23, 2011
0Patent Application Number
112348680
Date Filed
September 23, 2005
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08003783 17B-hydroxysteroid dehydrogenase inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08003783
Date of patent
August 23, 2011
Patent application number
11234868
Date Filed
September 23, 2005
Patent primary examiner
Find more entities like US Patent 8003783 17B-hydroxysteroid dehydrogenase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.